The spectrum of mutations predisposing to familial breast cancer in Poland

Advances in the use of PARP inhibitors for BRCA1/2-associated breast cancer: talazoparib

(2019) Kelly E McCann   Future Oncology

RAD50 germline mutations are associated with poor survival in BRCA1/2 -negative breast cancer patients

(2018) Cong Fan et al.   INTERNATIONAL JOURNAL OF CANCER

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial

(2018) Andrew Tutt et al.   NATURE MEDICINE

Gene panel testing of 5589 BRCA1/2 -negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer

(2018) Jan Hauke et al.   Cancer Medicine

Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing

(2018) Hsiao-Mei Lu et al.   JAMA Oncology

Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing

(2018) Elodie Girard et al.   INTERNATIONAL JOURNAL OF CANCER

Rare, protein-truncating variants in ATM , CHEK2 and PALB2 , but not XRCC2 , are associated with increased breast cancer risks

(2017) Brennan Decker et al.   JOURNAL OF MEDICAL GENETICS

Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers

(2016) Jon G Jonasson et al.   BRITISH JOURNAL OF CANCER

Genetic modifiers of CHEK2*1100delC-associated breast cancer risk

(2016) Taru A. Muranen et al.   GENETICS IN MEDICINE

Do founder mutations characteristic of some cancer sites also predispose to pancreatic cancer?

(2016) Marcin R. Lener et al.   INTERNATIONAL JOURNAL OF CANCER

Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers

(2015) Gaëlle Bougeard et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis

(2015) Cezary Cybulski et al.   LANCET ONCOLOGY

Germline RECQL mutations are associated with breast cancer susceptibility

(2015) Cezary Cybulski et al.   NATURE GENETICS

Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

(2015) Douglas F. Easton et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mutations predisposing to breast cancer in 12 candidate genes in breast cancer patients from Poland

(2014) C. Cybulski et al.   CLINICAL GENETICS

Recurrent mutations of BRCA1 and BRCA2 in Poland: an update

(2014) M. Szwiec et al.   CLINICAL GENETICS

Breast-Cancer Risk in Families with Mutations in PALB2

(2014) Antonis C. Antoniou et al.   NEW ENGLAND JOURNAL OF MEDICINE

A common nonsense mutation of the BLM gene and prostate cancer risk and survival

(2013) Andrzej Antczak et al.   GENE

Rare Mutations in XRCC2 Increase the Risk of Breast Cancer

(2012) D.J. Park et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Nonsense mutation p.Q548X in BLM, the gene mutated in Bloom’s syndrome, is associated with breast cancer in Slavic populations

(2012) Darya Prokofyeva et al.   BREAST CANCER RESEARCH AND TREATMENT

Lifetime Cancer Risks in Individuals with Germline PTEN Mutations

(2012) M.-H. Tan et al.   CLINICAL CANCER RESEARCH

Risk of Breast Cancer in Women With a CHEK2 Mutation With and Without a Family History of Breast Cancer

(2011) Cezary Cybulski et al.   JOURNAL OF CLINICAL ONCOLOGY

Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence

(2011) Ben Zhang et al.   LANCET ONCOLOGY

The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

(2010) A. McKenna et al.   GENOME RESEARCH

Cancer predisposing missense and protein truncatingBARD1mutations in non-BRCA1orBRCA2breast cancer families

(2010) Sylvia De Brakeleer et al.   HUMAN MUTATION

Rare, Evolutionarily Unlikely Missense Substitutions in ATM Confer Increased Risk of Breast Cancer

(2009) Sean V. Tavtigian et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Fast and accurate short read alignment with Burrows-Wheeler transform

(2009) H. Li et al.   BIOINFORMATICS

The Breast Cancer Susceptibility Mutation PALB2 1592delT Is Associated with an Aggressive Tumor Phenotype

(2009) T. Heikkinen et al.   CLINICAL CANCER RESEARCH

BRCA1 mutations and prostate cancer in Poland

(2009) Cezary Cybulski et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

CHEK2*1100delC Genotyping for Clinical Assessment of Breast Cancer Risk: Meta-Analyses of 26,000 Patient Cases and 27,000 Controls

(2008) Maren Weischer et al.   JOURNAL OF CLINICAL ONCOLOGY